Privium Fund Management B.V.

Position in MGTX — MeiraGTx Holdings plc

CIK 1795097 AMSTERDAM, P7

Position in MGTX

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$1,836,889

+$246,889 QoQ

Shares Held

212,112

+6.1% QoQ

Ownership

0.229%

of shares outstanding

% of Portfolio

0.38%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Privium Fund Management B.V. holds $142,100,239 across 32 Biotechnology names. MGTX ranks #19 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARWR	Arrowhead Pharmaceuticals, Inc.	366,936	$23,006,887
2	IONS	Ionis Pharmaceuticals Inc	290,024	$21,777,902
3	AXSM	Axsome Therapeutics, Inc.	58,729	$9,926,375
4	PRQR	ProQR Therapeutics N.V.	5,467,149	$8,856,781
5	QURE	uniQure N.V.	486,520	$7,954,602
6	RARE	Ultragenyx Pharmaceutical Inc.	364,802	$7,642,601
7	ARQT	Arcutis Biotherapeutics, Inc.	320,972	$7,562,100
8	BMRN	Biomarin Pharmaceutical Inc	92,305	$5,214,309

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,836,889	212,112	+6.1%	Shares	Sole	2026-05-05
2025-12-31	$1,590,000	200,000	+22.7%	Shares	Sole	2026-02-03
2025-09-30	$1,341,490	163,000	0.0%	Shares	Sole	2025-11-04
2025-06-30	$1,062,760	163,000	+39.3%	Shares	Sole	2025-07-30
2025-03-31	$793,260	117,000	-48.0%	Shares	Sole	2025-05-09
2024-12-31	$1,370,725	225,078	+5.2%	Shares	Sole	2025-02-11
2024-09-30	$892,213	213,960	+4.9%	Shares	Sole	2024-11-01
2024-06-30	$858,671	203,960	+70.0%	Shares	Sole	2024-08-01
2024-03-31	$728,308	119,985	—	Shares	Sole	2024-04-30
No filing history on record for this holder in this stock.